Advanced Medicine

Care must be taken to ensure patients understand the difference between gene therapy and the different kinds of gene editing.

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

Using CRISPR to engineer cell therapies with multiple gene knockouts could be limited by double-strand breaks.

Could zinc finger therapy hold the key to treating Alzheimer’s disease?

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

Lori Muffly believes collaboration and innovation – bolstered during the COVID-19 pandemic – will guide the future of stem cell transplant.

We speak with G-CON’s Maik Jornitz about his career and desire to give back by training the next generation.

Watch our video interview with Maik Jornitz.

Is pharma making progress in the development of off-the-shelf cell therapies?